Ebola treatments trial begins in DR Congo
The World Health Organization has launched a clinical trial for new treatments targeting the Bundibugyo Ebola virus in the Democratic Republic of Congo. The trial involves international collaboration to test two antiviral drugs in response to an outbreak that has caused hundreds of deaths.
Why it matters
The trial represents a critical effort to address a highly infectious disease that currently lacks approved medical treatments, potentially saving lives in affected regions.
A trial of potential treatments for the species of virus behind the current deadly Ebola outbreak in the Democratic Republic of Congo has begun, the World Health Organization (WHO) has announced.
The article provides factual reporting on a public health initiative by international organizations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in